NSW Government Invests $800,000 to Expand Cancer Clinical Trial Access in Rural Areas
Key Insights
The NSW Government has awarded $800,000 in Clinical Trials Fellowship grants to improve cancer (search) clinical trial access for rural and regional patients across the state.
Three grants worth $200,000 each focus on regional initiatives including remote trial delivery frameworks, teletrials, and engagement with underrepresented populations.
A fourth $200,000 grant supports the ACTIvate study for anaplastic thyroid cancer (search) immunotherapy, building on global evidence to address unique treatment challenges.
The NSW Government has allocated $800,000 in funding to expand cancer (search) clinical trial access for patients in rural and regional areas, addressing long-standing disparities in treatment options between metropolitan and remote communities. Cancer Institute NSW (search) awarded four Clinical Trials Fellowship grants worth approximately $200,000 each to researchers focused on increasing trial participation across underserved populations.
Regional Trial Access Initiatives
Three of the four grants specifically target regional access challenges. Dr Alexandra Smith from North West Cancer Centre (search)'s Oncology Clinical Trials and Research Unit received funding to build a framework for delivering clinical trial services remotely across the New England-North West area. The grant will support capacity building within the clinical trials unit, including developing local resources, recruiting research professionals, and educating staff to better support patient participation in trials.
"We want to ensure as many patients as possible have access to cancer (search) clinical trials, which could mean a treatment that might not have been available to them otherwise, or an opportunity to be part of research that will help other patients down the track," Dr Smith said. "In the New England-North West of NSW we have a different socio-demographic profile to bigger metro sites – so it's hugely significant for us to be able to harness and build on our local capacity to better include patients from more rural and remote areas in clinical trials."
Teletrials and Population Engagement
Eleanore Romney of Sydney Local Health District received a second $200,000 grant to establish teletrials designed to improve access for patients from rural and regional areas. This innovative approach aims to overcome geographic barriers that have traditionally limited trial participation for remote patients.
Acting Professor Daniel Steffens, also from Sydney Local Health District, was awarded the third regional grant to improve engagement with under-represented populations, including Aboriginal, culturally and linguistically diverse, and rural and remote communities in clinical trials.
Specialized Cancer Research
The fourth grant was awarded to Liza Nery of Royal North Shore Hospital to support the ACTIvate (Anaplastic Cancer (search) of the Thyroid Immunotherapy) study. This research builds on the latest global evidence to address the unique challenges of anaplastic thyroid cancer (search), a rare and aggressive form of the disease.
Patient Impact and Government Support
The funding initiative has already demonstrated real-world benefits for regional patients. Kate Jones, a Tamworth resident and Hunter New England Local Health District clinical trial participant, experienced firsthand the value of accessible trials after her bowel cancer (search) diagnosis in 2014.
"I was so happy to be offered a place in a clinical trial after my bowel cancer (search) diagnosis in 2014. The trial, which focused on my physical wellbeing, was my safety net," Jones said. "The network of people who are involved in trials, and their support are really important in regional communities. The trials give people who have finished their treatment and may not necessarily be looked at for months or years, extra support and that's so important, even if it's not physically, just emotionally."
Broader Investment Strategy
The Clinical Trials Fellowships represent part of Cancer Institute NSW (search)'s annual $5 million investment into cancer (search) clinical trials for children and adults, demonstrating the organization's commitment to providing treatment options through funding and partnerships with research professionals and communities.
Minister for Medical Research David Harris emphasized the government's commitment to equitable access: "The Clinical Trials Fellowships are key to ensuring equitable access to cancer (search) clinical trials across the state, particularly in our regions and in under-represented populations and I look forward to seeing the outcomes of this research."
NSW Chief Cancer (search) Officer and CEO Cancer Institute NSW (search) Professor Tracey O'Brien AM highlighted the broader community impact: "Strengthening research capacity and making cancer clinical trials accessible to everyone, no matter where they live, is key to improving cancer outcomes across NSW. Clinical trials don't just benefit individual patients; they serve entire communities and can be a lifeline for those facing cancer. Every person diagnosed with cancer deserves to be informed of their options, and these grants are helping to ensure that happens."